Indian Journal of Pain

REVIEW ARTICLE
Year
: 2017  |  Volume : 31  |  Issue : 1  |  Page : 9--12

Newer anticoagulants and their impact on interventional pain procedures


Babita Ghai, Nitin Ahuja 
 Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Correspondence Address:
Babita Ghai
Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh - 160 012
India

Heparins and coumarins have been ruling the anticoagulant class for the past 60 years, but the trend in the drug discovery, prominence of target-based approach, and high-throughput screening has brought newer molecules in the forefront. Newer oral anticoagulants (NOACs) with different therapeutic challenges have largely come up in the past 5 years and overcome the limitations of traditional anticoagulants. The debate for specific guidelines for their use has been on for years. Interventional pain physicians admonished that available guidelines for regional anesthesia in patients receiving anticoagulants were insufficient as pain procedures covered a far broader gamut reflecting diverse goals. Hence, experts from different groups and committees got together and summed up guidelines and stratified interventional pain procedures based separately on patient- and procedure-specific factors. Here, in this review, we discuss the NOACs and their impact on interventional pain procedures.


How to cite this article:
Ghai B, Ahuja N. Newer anticoagulants and their impact on interventional pain procedures.Indian J Pain 2017;31:9-12


How to cite this URL:
Ghai B, Ahuja N. Newer anticoagulants and their impact on interventional pain procedures. Indian J Pain [serial online] 2017 [cited 2019 Sep 18 ];31:9-12
Available from: http://www.indianjpain.org/article.asp?issn=0970-5333;year=2017;volume=31;issue=1;spage=9;epage=12;aulast=Ghai;type=0